MEG Maps™ powered by TRIUX™ neo and MEGreview™

The world’s most advanced MEG solution

Book a demo

An end-to-end solution to help you establish and grow a successful MEG program 

Experience a cost-effective, accurate, and multidisciplinary imaging modality designed to support clinical workflows with MEG Maps™ powered by TRIUX™ neo and MEGreview™.

The MEG Maps™ Platform offers a comprehensive, end-to-end solution which aims to strengthen the best practices in clinical MEG and advance the use of MEG in patient care.

Epilepsy localization maps for pre-surgical evaluation.

Primary sensory and motor maps for surgical planning.

With MEG Maps™, you can ensure that every step of the process is optimised to deliver the best possible care to patients.

Designed specifically for your clinical workflow

Scan

Industry leading scan acquisition with TRIUX™ neo includes guided workflows and training for staff.

Analyze

Guided workflows for electrophysiology review and functional mapping.

Report

Patient-centric data access and management, including DICOM integration with image archiving (PACS).

Secure

Secure by design software for cybersecurity concerns.

Secure by design

Expanding clinical and research utility

MEG Maps™ expandible flexible platform aims to:

  • Establish secure by design clinical software practices
  • Integrate clinical workflows
  • Support open-source and translational research tools
  • Increase knowledge sharing
  • Facilitate multi-center studies
  • Standardize scans with industry standards, such as MEG-BIDS

Strategic Partnerships – Focused on making MEG mainstream

Collaborative development at
the CORE of MEG Maps™

MEGreview™

  • Establishing best practices
  • Streamlined workflows for epilepsy and functional mapping

Collaborative development for FUTURE* integration to MEG Maps™

Multimodal cloud-based viewer:

  • MEG localization
  • MEG, EEG, iEEG signals
  • fMRI, PET, SPECT surface source activity

Multimodal analysis

  • Dynamic network reconstruction for epilepsy
  • Propagation analysis
  • Automatic spike and ictal events detection

* FIND Neuro is not sold by MEGIN. FIND Neuro is a work in progress and not available for sale.

Industry leading scan acquisition
with the TRIUX™ neo and MEGreview™

Key features:

Ultra-resilient ARMOR™ sensors and uniquely effective interference elimination tools.
Patented signal-level movement compensation technology for elimination of head movement artifacts.
Internal helium recycler (IHR) to reduce helium consumption and costs.
Seated, reclined, or supine patient positioning options with adjustable seating height.
Able to scan and filter sources of magnetic noise, including select implants and metallic objects.

Key features:

Ultra-resilient ARMOR™ sensors and uniquely effective interference elimination tools.

Patented signal-level movement compensation technology for elimination of head movement artifacts.

Internal helium recycler (IHR) to reduce helium consumption and costs.

Seated, reclined, or supine patient positioning options with adjustable seating height.

Able to scan and filter sources of magnetic noise, including select implants and metallic objects.

Interested in learning more?

Book a demo

“The TRIUX™ neo MEG scanner is fundamentally important for the continuation of our world-leading translational research aimed at discovering and testing new treatments as well as procedures for people with mental health or brain disorders.” ​

Professor Kia Nobre, Director, Oxford Centre of Human Brain Activity (OHBA)

“The new MEGIN TRIUX™ neo machine will allow advanced signal analysis and improved signal-to-noise, which matters greatly as we tackle questions related to what are arguably the most fascinating and difficult participants, infants and young children.”​

Patricia Kuhl, Co-Director, Institute for Learning & Brain Sciences (I-LABS)

“MEG is a powerful technology that offers a non-invasive, comprehensive assessment of critical brain functions — including language, motor, auditory and visual processing — with unprecedented ability to determine precisely where and when activity occurs in the brain. Such assessments not only aid in guiding care and treatment decisions but also serve as a roadmap for future research and discoveries.” 

Abbas Babajani-Feremi, PhD, Associate Professor of Neurology and Director of the MEG Lab, UF Health Normal Fixel Institute

“The TRIUX™ neo acquisition ensures that SFU’s Image Tech Lab continues to be globally competitive in advanced brain imaging – while benefiting patients and their families across the region.”​

Dugan O’Neil, Vice President, Research and Innovation, Simon Fraser University

Our current installed base is looking forward to upgrading to the new platform.

Find out how MEG Maps™ powered by TRIUX™ neo and MEGreview™ can support your institution

Contact us today